ADORA2A and amyotrophic lateral sclerosis: These pathophysiological findings may suggest that A2AR function and/or sensitivity alters between pre-symptomatic to symptomatic phases in ALS, which is in line with A2AR expression change in SOD1G93A mice, as mentioned previously.